Plenary Sessions

 

 

Sunday, October 14, 10:00 – 11:15
In Vivo Molecular Diagnosis of Cognitive Disorders – A Paradigm Change (incl. Marie Curie Lecture)
Chairpersons: Roberto Delgado Bolton / Wim Oyen

 

10:00 – 10:25 Alzheimer’s Disease Criteria: The Role of Markers of Pathology Prof. Bruno Dubois (FR)
10:25 – 10:50 Amypad: A Randomized Clinical Trial to Validate the Impact of Amyloid PET Prof. Frederik Barkhof (NL)
10:50 – 11:15 Marie Curie Lecture: Tau PET Imaging: A History of Challenges and Success Prof. Victor Villemagne (AU)

 

 

 

Monday, October 15, 10:00 – 11:15
To Do, or Not to Do Dosimetry, that is the Question
Chairpersons:  Francesco Giammarile / Kristoff Muylle

 

10:00 – 10:25 Personalized Therapies in Oncology: Pro and Cons Prof. Silke Gillessen (CH) 
10:25 – 10:50 Need of Careful Personalized Dosimetric Evaluation in Radionuclide Therapy Dr. Glenn Flux (UK)
10:50 – 11:15 Dosimetry in Clinical Radionuclide Therapy: The Devil is in the Detail Prof. Lisa Bodei (US)

 

 

Tuesday, October 16, 10:00 – 11:15
The Fascinating World of Molecules
Chairpersons: Jan Pruim / Jolanta Kunikowska

 

10:00 – 10:25 The Fascinating World of Molecules Prof. Bernard L. Feringa (NL)
10:25 – 10:50 Coronary Flow for Assessment of Myocardial Ischemia – The ‘Hot’ Topic in Cardiology Prof. Jan Piek (NL)
10:50 – 11:15 PET to Evaluate Response to Therapy – Theranostic and Beyond Prof. Nicolas Aide (FR)

 

 

Wednesday, October 17, 12:15 – 13:15
Highlights Lecture
Chairpersons:  Francesco Giammarile / Kristoff Muylle

 

12:15 – 13:15 Prof. Ken Herrmann (DE)
12:15 – 13:15 Dr. Fijs van Leeuwen (NL)